DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pediamycin is a drug marketed by Ross Labs and Arbor Pharms Llc and is included in three NDAs.
The generic ingredient in PEDIAMYCIN is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
A generic version of PEDIAMYCIN was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Ross Labs||PEDIAMYCIN||erythromycin ethylsuccinate||GRANULE;ORAL||062305-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Ross Labs||PEDIAMYCIN||erythromycin ethylsuccinate||TABLET, CHEWABLE;ORAL||062306-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Ross Labs||PEDIAMYCIN||erythromycin ethylsuccinate||SUSPENSION/DROPS;ORAL||062305-002||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|